STRATA Skin Sciences (SSKN) Capital Expenditures Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 27.22% |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn | -16.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16.26% |
| Sep 30, 2025 | 96.26% |
| Jun 30, 2025 | -117.68% |
| Mar 31, 2025 | -72.55% |
| Dec 31, 2024 | -4.77% |
| Sep 30, 2024 | -451.55% |
| Jun 30, 2024 | -79.74% |
| Mar 31, 2024 | -59.54% |
| Dec 31, 2023 | 1.12% |
| Sep 30, 2023 | -136.81% |
| Jun 30, 2023 | 104.93% |
| Mar 31, 2023 | 163.92% |
| Dec 31, 2022 | 50.35% |
| Sep 30, 2022 | -50.14% |
| Jun 30, 2022 | 14.46% |
| Mar 31, 2022 | -8.24% |
| Dec 31, 2021 | 58.71% |
| Sep 30, 2021 | -26.95% |
| Dec 31, 2020 | 547.27% |
| Dec 31, 2019 | 1,471.43% |
| Dec 31, 2018 | 800.00% |
| Mar 31, 2018 | -97.00% |
| Dec 31, 2013 | -87.04% |
| Sep 30, 2013 | -51.75% |
| Jun 30, 2013 | 116.28% |
| Mar 31, 2013 | 302.20% |
| Dec 31, 2012 | 5,382.23% |
| Sep 30, 2012 | 8,073.38% |
| Jun 30, 2012 | 4,141.10% |
| Mar 31, 2012 | 5,237.85% |
| Dec 31, 2011 | 618.64% |
| Sep 30, 2011 | -93.30% |